Anti-CD79b Reference Antibody (polatuzumab vedotin-piiq)
Product Sizes
100 ug
£635.00
CHB256-100UG
1 mg
£2295.00
CHB256-1MG
About this Product
- SKU:
- CHB256
- Additional Names:
- IgG1|polatuzumab vedotin-piiq
- Application:
- Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
- Buffer:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Clonality:
- Recombinant Monoclonal
- Concentration:
- 1 mg/ml
- Extra Details:
- Polatuzumab vedotin (Polivy) is an ADC consisting of a CD79b-directed antibody and Monomethyl auristatin E (MMAE) that can be used in combination with bendamustine and rituximab for the treatment of adult patients with at least two relapses or refractory diffuse large B-cell lymphoma. Polatuzumab vedotin binds to CD79b and is internalized by tumor cells. MMAE is cleaved from cells by lysosomal protease and promotes tumor cell apoptosis by inhibiting microtubule formation.
- Formulation:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Immunogen:
- CD79b
- Isotype:
- IgG1
- Physical State:
- Lyophilized
- Purity:
- >90%
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Specificity:
- CD79b
- Storage Conditions:
- -70[o]C Avoid freeze/thaw cycles., 2-8[o]C
- Supplier:
- Sanyou Biopharmaceuticals
- Type:
- Antibody: Biosimilar Antibody
- Manufacturer's Data Sheet:CHB256
